6/18/2024  9:59:55 PM Chg. -0.49 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
12.68USD -3.72% 99,862
Turnover: 1.27 mill.
-Bid Size: - -Ask Size: - 48.82 bill.USD - -

Business description

Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
 

Management board & Supervisory board

CEO
Christophe Weber
Management board
Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa
Supervisory board
Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed
 

Company data

Name: Takeda Pharmaceutical Company Ltd.
Address: 1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan
Phone: +81-3-3278-2306
Fax: +81-3-3278-2268
E-mail: -
Internet: www.takeda.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 3/31
Free Float: -
IPO date: -

Investor relations

Name: Christopher O'Reilly
IR phone: +81-3-3278-2037
IR Fax: +81-3-3278-2741
IR e-mail: takeda.ir.contact@takeda.com

Company calendar

CW 26 | 6/27/2024 Dividend Payment
 

Main Shareholders